MarketScreener Strategies Vertex Pharmaceuticals Incorporated
Stocks
VRTX
US92532F1003
Pharmaceuticals
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 526.20 USD | +6.07% |
|
+12.74% | +17.05% |
| 06:19pm | Vertex Shares Rise as Rival Sionna's Cystic-Fibrosis Trial Fails to Meet Endpoint | DJ |
| 03:05pm | Sionna scraps genetic disorder drug program after trial setback; shares tank | RE |
MarketScreener Strategies
Search
 | Vertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease | December 11, 2023 at 01:47 pm |
 | Vertex Pharmaceuticals Incorporated : Confirms growth trajectory | May 04, 2023 at 04:35 pm |
 | Vertex Pharmaceuticals : A very promising pipeline | January 11, 2023 at 01:20 pm |
No results match your criteria
- Stock Market
- Stocks
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
